NCT06140511

Brief Summary

This study aims at the constitution of a large cohort of adult subjects without Rapid eye movement (REM) sleep behavior disorder (RBD), among whom subjects with isolated REM sleep without atonia (RSWA) will be identified; their long-term follow-up, compared to subjects without RSWA, will be useful in the next years to understand if this condition represents a risk factor for the future development of RBD, a condition in which the development of a neurodegenerative disorder (especially synucleinopathy) is highly probable. This will allow to obtain a wide time window for the establishment of prevention and neuroprotection in these subjects, with the goal to avoid or delay the development of the RBD\>synucleinopathy sequence. All Units will recruit a large number of subjects without RBD undergoing a polysomnography (PSG) recording, with a shared protocol, and the data collected will be stored on a web-based common database. Subjects showing RSWA in their PSG will be identified and used as a prospective study group, which will start at the end of the recruitment of this project.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 20, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

November 20, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2025

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.5 years

First QC Date

October 16, 2023

Last Update Submit

November 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Enrollment of 600 subjects without and with RSWA.

    Constitution of a large cohort of 600 subjects without and with RSWA.

    18 months

Interventions

PolysomnographyDIAGNOSTIC_TEST

Polysomnography for the assessment of the presence of REM sleep without atonia (RSWA). All Units will recruit subjects to be included in the cohort and this will ensure the inclusion of a sufficiently large sample of subjects without and, especially, with RSWA. From a previous study \[Ferri et al. Sleep 2018:zsy187\] that we carried out on a similar group of subjects, we know that we can expect to find RSWA in approximately 14% of individuals.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all participants undergoing full-night laboratory sleep PSG recording

You may qualify if:

  • age ≥18 years
  • sharing bedroom with a partner or roommate
  • absence of a severe health, neurological, or cognitive problem that would impair the comprehension of the study tasks
  • sleep recording without important artifact in the chin electromyographic signals, and presence of at least 5 min of REM sleep.

You may not qualify if:

  • previous diagnosis of RBD,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (19)

  • Dong X, Mondello S, Kobeissy F, Talih F, Ferri R, Mechref Y. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder. Electrophoresis. 2018 Dec;39(24):3096-3103. doi: 10.1002/elps.201800316. Epub 2018 Sep 12.

    PMID: 30168606BACKGROUND
  • Dijkstra F, Viaene M, Crosiers D, De Volder I, Cras P. Frequency and characteristic features of REM sleep without atonia. Clin Neurophysiol. 2019 Oct;130(10):1825-1832. doi: 10.1016/j.clinph.2019.07.018. Epub 2019 Jul 27.

    PMID: 31401491BACKGROUND
  • Ferri R, Manconi M, Plazzi G, Bruni O, Vandi S, Montagna P, Ferini-Strambi L, Zucconi M. A quantitative statistical analysis of the submentalis muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder. J Sleep Res. 2008 Mar;17(1):89-100. doi: 10.1111/j.1365-2869.2008.00631.x.

    PMID: 18275559BACKGROUND
  • Ferri R, Rundo F, Manconi M, Plazzi G, Bruni O, Oldani A, Ferini-Strambi L, Zucconi M. Improved computation of the atonia index in normal controls and patients with REM sleep behavior disorder. Sleep Med. 2010 Oct;11(9):947-9. doi: 10.1016/j.sleep.2010.06.003.

    PMID: 20817596BACKGROUND
  • Ferri R, Bruni O, Fulda S, Zucconi M, Plazzi G. A quantitative analysis of the submentalis muscle electromyographic amplitude during rapid eye movement sleep across the lifespan. J Sleep Res. 2012 Jun;21(3):257-63. doi: 10.1111/j.1365-2869.2011.00958.x. Epub 2011 Sep 28.

    PMID: 21955170BACKGROUND
  • Ferri R, Fulda S, Cosentino FI, Pizza F, Plazzi G. A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder. Sleep Med. 2012 Jun;13(6):707-13. doi: 10.1016/j.sleep.2012.01.003. Epub 2012 Mar 20.

    PMID: 22440085BACKGROUND
  • Ferri R, Arico D, Cosentino FII, Lanuzza B, Chiaro G, Manconi M. REM sleep without atonia with REM sleep-related motor events: broadening the spectrum of REM sleep behavior disorder. Sleep. 2018 Dec 1;41(12). doi: 10.1093/sleep/zsy187.

    PMID: 30239958BACKGROUND
  • Ferri R, Mogavero MP, Bruni O, Plazzi G, Schenck CH, DelRosso LM. Increased chin muscle tone during all sleep stages in children taking selective serotonin reuptake inhibitor antidepressants and in children with narcolepsy type 1. Sleep. 2021 Nov 12;44(11):zsab147. doi: 10.1093/sleep/zsab147.

    PMID: 34111296BACKGROUND
  • Figorilli M, Lanza G, Congiu P, Lecca R, Casaglia E, Mogavero MP, Puligheddu M, Ferri R. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review. Brain Sci. 2021 Nov 30;11(12):1588. doi: 10.3390/brainsci11121588.

    PMID: 34942893BACKGROUND
  • Lanza G, Cosentino FII, Lanuzza B, Tripodi M, Arico D, Figorilli M, Puligheddu M, Fisicaro F, Bella R, Ferri R, Pennisi M. Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson's Disease with RBD. J Clin Med. 2022 Apr 20;11(9):2291. doi: 10.3390/jcm11092291.

    PMID: 35566417BACKGROUND
  • Lanza G, Arico D, Lanuzza B, Cosentino FII, Tripodi M, Giardina F, Bella R, Puligheddu M, Pennisi G, Ferri R, Pennisi M. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration? Sleep. 2020 Mar 12;43(3):zsz242. doi: 10.1093/sleep/zsz242.

    PMID: 31599326BACKGROUND
  • Lee K, Baron K, Soca R, Attarian H. The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants. J Clin Sleep Med. 2016 Mar;12(3):351-5. doi: 10.5664/jcsm.5582.

    PMID: 26446247BACKGROUND
  • Miyamoto M, Miyamoto T, Kubo J, Yokota N, Hirata K, Sato T. Brainstem function in rapid eye movement sleep behavior disorder: the evaluation of brainstem function by proton MR spectroscopy (1H-MRS). Psychiatry Clin Neurosci. 2000 Jun;54(3):350-1. doi: 10.1046/j.1440-1819.2000.00710.x.

    PMID: 11186109BACKGROUND
  • Mondello S, Kobeissy F, Mechref Y, Zhao J, Talih FR, Cosentino F, Antelmi E, Moresco M, Plazzi G, Ferri R. Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach. Neurology. 2018 Oct 30;91(18):e1710-e1715. doi: 10.1212/WNL.0000000000006439. Epub 2018 Sep 26.

    PMID: 30258025BACKGROUND
  • Postuma RB, Iranzo A, Hu M, Hogl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

    PMID: 30789229BACKGROUND
  • Postuma RB, Gagnon JF, Tuineaig M, Bertrand JA, Latreille V, Desjardins C, Montplaisir JY. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep. 2013 Nov 1;36(11):1579-85. doi: 10.5665/sleep.3102.

    PMID: 24179289BACKGROUND
  • Puligheddu M, Figorilli M, Serra A, Laccu I, Congiu P, Tamburrino L, de Natale ER, Ginatempo F, Deriu F, Loi G, Fantini ML, Schenck CH, Ferri R. REM Sleep without atonia correlates with abnormal vestibular-evoked myogenic potentials in isolated REM sleep behavior disorder. Sleep. 2019 Sep 6;42(9):zsz128. doi: 10.1093/sleep/zsz128.

    PMID: 31310647BACKGROUND
  • Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Doring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Moller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22.

    PMID: 23886593BACKGROUND
  • Miglis MG, Adler CH, Antelmi E, Arnaldi D, Baldelli L, Boeve BF, Cesari M, Dall'Antonia I, Diederich NJ, Doppler K, Dusek P, Ferri R, Gagnon JF, Gan-Or Z, Hermann W, Hogl B, Hu MT, Iranzo A, Janzen A, Kuzkina A, Lee JY, Leenders KL, Lewis SJG, Liguori C, Liu J, Lo C, Ehgoetz Martens KA, Nepozitek J, Plazzi G, Provini F, Puligheddu M, Rolinski M, Rusz J, Stefani A, Summers RLS, Yoo D, Zitser J, Oertel WH. Biomarkers of conversion to alpha-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 2021 Aug;20(8):671-684. doi: 10.1016/S1474-4422(21)00176-9.

Biospecimen

Retention: SAMPLES WITH DNA

All units, whenever possible and especially for subjects with RSWA, will obtain blood samples which will be adequately stored for a final proteomic and metabolomic analysis in order to establish if omics signatures are expressed in them similar to those that we have already found in RBD patients.

MeSH Terms

Conditions

REM Sleep Behavior Disorder

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

REM Sleep ParasomniasParasomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Raffaele Ferri, MD

    Oasi Research Institute-IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lorenzo Mercadante, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2023

First Posted

November 20, 2023

Study Start

November 20, 2023

Primary Completion

May 19, 2025

Study Completion

May 19, 2025

Last Updated

November 22, 2023

Record last verified: 2023-11